Zapletal Ch, Heesen Ch, Origer J, Pauthner M, Pech O, Ell Ch, Lorenz Dietmar
Department of Surgery, Dr. Horst-Schmidt-Klinik, Ludwig-Erhard-Str. 100, 65199, Wiesbaden, Germany,
World J Surg. 2014 Jun;38(6):1444-52. doi: 10.1007/s00268-013-2410-1.
The Merendino (MER) procedure has been evaluated as an alternative to transthoracic esophageal resection (TER) for early stage Barrett's carcinoma. Apart from reducing morbidity and mortality, improvements concerning postoperative health-related quality of life (HRQL) have been postulated. The aim of our study was to compare HRQL between these procedures.
Between July 2000 and July 2007, 117 patients with early Barrett's carcinoma underwent surgery. Patients with tumor recurrence were excluded from the study. HRQL was assessed 1 and 2 years after surgery using the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (EORTC-QLQ-C30) and the QLQ-OES18 module. Patients recently diagnosed with early Barrett's carcinoma served as controls. Symptoms that showed a difference of more than ten between the control and the study groups were considered clinically relevant and were tested for significant differences between the study groups using the Mann-Whitney U test (p < 0.05).
The response rates for the questionnaires ranged between 70 and 93 %. In the MER group, more items reflected a clinical relevant impairment of HRQL than in the TER group. Significant complaints in the MER group included nausea/vomiting, appetite loss, local pain, difficulties with social eating, and choking. Moreover, we found a significant restriction concerning global health and emotional and social functioning in this group 1 year after surgery. 2 years postoperatively, hardly any differences between the operative techniques could be detected. The only symptom in favor of the MER procedure was a better dysphagia score postoperatively.
Our study suggests that MER procedure is not superior to subtotal esophagectomy with regard to HRQL.
对于早期巴雷特食管癌,已对梅伦迪诺(MER)手术作为经胸食管切除术(TER)的替代方法进行了评估。除了降低发病率和死亡率外,还假定该手术在改善术后健康相关生活质量(HRQL)方面具有优势。我们研究的目的是比较这两种手术方式的HRQL。
2000年7月至2007年7月期间,117例早期巴雷特食管癌患者接受了手术。肿瘤复发的患者被排除在研究之外。术后1年和2年使用欧洲癌症研究与治疗组织(EORTC)生活质量核心问卷(EORTC-QLQ-C30)和QLQ-OES18模块评估HRQL。近期诊断为早期巴雷特食管癌的患者作为对照。对照组与研究组之间差异超过10的症状被视为具有临床相关性,并使用曼-惠特尼U检验(p<0.05)对研究组之间的显著差异进行检验。
问卷的回复率在70%至93%之间。在MER组中,与TER组相比,更多项目反映出HRQL存在临床相关损害。MER组的显著主诉包括恶心/呕吐、食欲减退、局部疼痛、社交进食困难和呛噎。此外,我们发现该组术后1年在总体健康以及情感和社会功能方面存在显著限制。术后2年,几乎未发现手术技术之间存在任何差异。支持MER手术的唯一症状是术后吞咽困难评分更好。
我们的研究表明,在HRQL方面,MER手术并不优于次全食管切除术。